• Corcept Therapeutics average return on equity for 2023 was 19.87, a 19.98% increase from 2022.
• Corcept Therapeutics average return on equity for 2022 was 24.83, a 20.59% decline from 2021.
• Corcept Therapeutics average return on equity for 2021 was 20.59, a 22.65% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.